ArticleJournal for immunotherapy of cancer2020

Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity.

Tae Hee Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.